Patent · US Active

Compounds and their uses for alleviating menopause-associated symptoms

US11666585B2 · kind B2 · utility

6Cited by

41References

21Claims

0Family size

Assignee

ESTETRA SRL · BE

Inventors

Melanie Taziaux · Liège, BE
Glwadys Rausin · Trooz, BE
Maud Jost · Liège, BE
Marie Mawet · Angleur, BE

Key dates

Filing date	Oct 11, 2022
Grant date	Jun 6, 2023
Priority date	—
Expiry date	Oct 11, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component.The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.